Luca Valenti
Luca Valenti
Associate Professor of Internal Medicine, UniversitÓ degli Studi di Milano, Fondazione Ca' Granda
Email verificata su unimi.it
Titolo
Citata da
Citata da
Anno
Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes
AL Fracanzani, L Valenti, E Bugianesi, M Andreoletti, A Colli, E Vanni, ...
Hepatology 48 (3), 792-798, 2008
6442008
Nuclear trapping of the forkhead transcription factor FoxO1 via Sirt-dependent deacetylation promotes expression of glucogenetic genes
D Frescas, L Valenti, D Accili
Journal of Biological Chemistry 280 (21), 20589-20595, 2005
5472005
Homozygosity for the patatin‐like phospholipase‐3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease
L Valenti, A Al‐Serri, AK Daly, E Galmozzi, R Rametta, P Dongiovanni, ...
Hepatology 51 (4), 1209-1217, 2010
4862010
Tumor necrosis factor α promoter polymorphisms and insulin resistance in nonalcoholic fatty liver disease
L Valenti, AL Fracanzani, P Dongiovanni, G Santorelli, A Branchi, E Taioli, ...
Gastroenterology 122 (2), 274-280, 2002
3822002
Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease
P Dongiovanni, S Petta, C Maglio, AL Fracanzani, R Pipitone, E Mozzi, ...
Hepatology 61 (2), 506-514, 2015
2972015
Hyperferritinemia, iron overload, and multiple metabolic alterations identify patients at risk for nonalcoholic steatohepatitis
S Fargion, M Mattioli, AL Fracanzani, M Sampietro, D Tavazzi, P Fociani, ...
The American journal of gastroenterology 96 (8), 2448-2455, 2001
2862001
Iron depletion by phlebotomy improves insulin resistance in patients with nonalcoholic fatty liver disease and hyperferritinemia: evidence from a case-control study
L Valenti, AL Fracanzani, P Dongiovanni, E Bugianesi, G Marchesini, ...
American Journal of Gastroenterology 102 (6), 1251-1258, 2007
2792007
Iron in fatty liver and in the metabolic syndrome: a promising therapeutic target
P Dongiovanni, AL Fracanzani, S Fargion, L Valenti
Journal of hepatology 55 (4), 920-932, 2011
2612011
Carotid artery intima-media thickness in nonalcoholic fatty liver disease
AL Fracanzani, L Burdick, S Raselli, P Pedotti, L Grigore, G Santorelli, ...
The American journal of medicine 121 (1), 72-78, 2008
2532008
The MBOAT7-TMC4 variant rs641738 increases risk of nonalcoholic fatty liver disease in individuals of European descent
RM Mancina, P Dongiovanni, S Petta, P Pingitore, M Meroni, R Rametta, ...
Gastroenterology 150 (5), 1219-1230. e6, 2016
2522016
Patatin‐like phospholipase domain‐containing 3 I148M polymorphism, steatosis, and liver damage in chronic hepatitis C
L Valenti, MG Rumi, E Galmozzi, A Aghemo, B Del Menico, S De Nicola, ...
Hepatology 53 (3), 791-799, 2011
2492011
I148M patatin‐like phospholipase domain‐containing 3 gene variant and severity of pediatric nonalcoholic fatty liver disease
L Valenti, A Alisi, E Galmozzi, A Bartuli, B Del Menico, A Alterio, ...
Hepatology 52 (4), 1274-1280, 2010
2492010
Statin use and non-alcoholic steatohepatitis in at risk individuals
P Dongiovanni, S Petta, V Mannisto, RM Mancina, R Pipitone, V Karja, ...
Journal of hepatology 63 (3), 705-712, 2015
2352015
HFE genotype, parenchymal iron accumulation, and liver fibrosis in patients with nonalcoholic fatty liver disease
L Valenti, AL Fracanzani, E Bugianesi, P Dongiovanni, E Galmozzi, ...
Gastroenterology 138 (3), 905-912, 2010
2342010
Genetics and epigenetics of NAFLD and NASH: clinical impact
M Eslam, L Valenti, S Romeo
Journal of hepatology 68 (2), 268-279, 2018
2282018
PNPLA3 has retinyl-palmitate lipase activity in human hepatic stellate cells
C Pirazzi, L Valenti, BM Motta, P Pingitore, K Hedfalk, RM Mancina, ...
Human molecular genetics 23 (15), 4077-4085, 2014
2092014
Association between the PNPLA3 (rs738409 C>G) variant and hepatocellular carcinoma: Evidence from a meta‐analysis of individual participant data
E TrÚpo, P Nahon, G Bontempi, L Valenti, E Falleti, HD Nischalke, ...
Hepatology 59 (6), 2170-2177, 2014
1842014
Genetic variants regulating insulin receptor signalling are associated with the severity of liver damage in patients with non-alcoholic fatty liver disease
P Dongiovanni, L Valenti, R Rametta, AK Daly, V Nobili, E Mozzi, ...
Gut 59 (2), 267-273, 2010
1612010
Genetic predisposition in NAFLD and NASH: impact on severity of liver disease and response to treatment
P Dongiovanni, Q M Anstee, L Valenti
Current pharmaceutical design 19 (29), 5219-5238, 2013
1562013
A 360-degree overview of paediatric NAFLD: recent insights
V Nobili, G Svegliati-Baroni, A Alisi, L Miele, L Valenti, P Vajro
Journal of hepatology 58 (6), 1218-1229, 2013
1562013
Il sistema al momento non pu˛ eseguire l'operazione. Riprova pi¨ tardi.
Articoli 1–20